한국지질동맥경화학회 학술대회

LDL versus inflammation: what remains after aggressive lipid lowering?

Emerging anti-inflammatory therapies in ASCVD: canakinumab, NLRP3 inhibitors, and beyond

Colchicine for secondary prevention in ASCVD

Immune mechanisms of residual cardiovascular risk: from oxidation-specific epitopes to therapeutic targets

The race to the bottom: intensive LDL-C lowering in very high-risk Asian patients

Combination therapy in high-risk patients: early vs stepwise approach

Practical approaches to statin intolerance: from clinical trials to real-world solutions

Sex differences in lymphatic function and atherosclerosis outcomes

Tirzepatide and cardiometabolic outcomes: implications of dual GLP-1/GIP agonism

Effects of SGLT2 inhibitors on lipid metabolism: mechanisms and clinical implications

Paving the road for optimal LDL-C management: new evidence on intensive LDL-C targeting from the Ez-PAVE trial

Lipid-lowering therapy in people living with HIV (PLWH)

Lipid-lowering therapy in cancer patients and survivors

Lipid-lowering therapy in patients with CKD

Cardiovascular prevention in hemodialysis: is omega-3 back?

Integrated management of hypertension and dyslipidemia for cardiovascular disease prevention

TBD (Lecture Title)

Evolution of vulnerable plaques: from natural history to preventive intervention

High-risk plaque features on CCTA: identification and clinical implications

Intravascular imaging of vulnerable plaques: insights from IVUS and OCT

Coronary physiology and plaque vulnerability: integrative relationship and prognostic implications

Defining residual cardiovascular risk in the post-LDL era: unmet needs and mechanisms

Targeting residual risk: Lp(a), triglyceride-rich lipoproteins, and inflammation

Beyond less is more: navigating residual thrombotic and inflammatory risk in AF and stable CAD

A new oral LDL-C lowering agent with proven CV benefit: bempedoic acid

Oxidized phospholipids on lipoprotein(a): a key driver of atherothrombosis?

Does lipoprotein(a) promote thrombosis? evidence from genetics and population studies

Epidemiology and cardiovascular events: what have we learned?

Cutting edge care of pitavastatin with ezetimibe combination therapy

TBD (Lecture Title)

Hypertriglyceridemia and remnant cholesterol in diabetes

Arterial stiffness and vascular aging in diabetes

Coronary artery calcium and subclinical atherosclerosis in diabetes

Lipid management in primary prevention: who, when, and how aggressive?

Every minute counts: exercise snacks for better health and life’s essential 8

Advancing cardiovascular management through vaccination

Non-inflammatory function of dendritic cell in the regulation of obesity-associated heart failure

Hepatic lipotoxicity and fibrotic remodeling in metabolic liver disease

From lipidomics to systems biology: decoding metabolic networks